186 related articles for article (PubMed ID: 19116653)
1. Reassessment of CXCR4 chemokine receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-2.
Fischer T; Nagel F; Jacobs S; Stumm R; Schulz S
PLoS One; 2008; 3(12):e4069. PubMed ID: 19116653
[TBL] [Abstract][Full Text] [Related]
2. Reassessment of sst3 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-5.
Lupp A; Nagel F; Doll C; Röcken C; Evert M; Mawrin C; Saeger W; Schulz S
Neuroendocrinology; 2012; 96(4):301-10. PubMed ID: 22414742
[TBL] [Abstract][Full Text] [Related]
3. Reassessment of sst(5) somatostatin receptor expression in normal and neoplastic human tissues using the novel rabbit monoclonal antibody UMB-4.
Lupp A; Hunder A; Petrich A; Nagel F; Doll C; Schulz S
Neuroendocrinology; 2011; 94(3):255-64. PubMed ID: 21952553
[TBL] [Abstract][Full Text] [Related]
4. Reassessment of endothelin receptor A expression in normal and neoplastic human tissues using the novel rabbit monoclonal antibody UMB-8.
Lupp A; Mann A; Heeb A; Kaemmerer D; Sänger J; Evert M; Evert K; Mawrin C; Schulz S
Peptides; 2015 Apr; 66():19-25. PubMed ID: 25708416
[TBL] [Abstract][Full Text] [Related]
5. Reassessment of sst2 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-1.
Fischer T; Doll C; Jacobs S; Kolodziej A; Stumm R; Schulz S
J Clin Endocrinol Metab; 2008 Nov; 93(11):4519-24. PubMed ID: 18697876
[TBL] [Abstract][Full Text] [Related]
6. Reevaluation of sst₁ somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-7.
Lupp A; Nagel F; Schulz S
Regul Pept; 2013 May; 183():1-6. PubMed ID: 23466804
[TBL] [Abstract][Full Text] [Related]
7. Reassessment of SST4 Somatostatin Receptor Expression Using SST4-eGFP Knockin Mice and the Novel Rabbit Monoclonal Anti-Human SST4 Antibody 7H49L61.
Lupp A; Ehms B; Stumm R; Göckeritz J; Mawrin C; Schulz S
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884783
[TBL] [Abstract][Full Text] [Related]
8. UMB-3, a novel rabbit monoclonal antibody, for assessing μ-opioid receptor expression in mouse, rat and human formalin-fixed and paraffin-embedded tissues.
Lupp A; Richter N; Doll C; Nagel F; Schulz S
Regul Pept; 2011 Feb; 167(1):9-13. PubMed ID: 20851148
[TBL] [Abstract][Full Text] [Related]
9. Characterization and application of two novel monoclonal antibodies against human CXCR4: cell proliferation and migration regulation for glioma cell line in vitro by CXCR4/SDF-1alpha signal.
Cheng Z; Zhou S; Wang X; Xie F; Wu H; Liu G; Wang Q; Chen Y; Hu Y; Lu B; Zhang X
Hybridoma (Larchmt); 2009 Feb; 28(1):33-41. PubMed ID: 19239368
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
Schulz S; Röcken C; Mawrin C; Weise W; Höllt V; Schulz S
Clin Cancer Res; 2004 Dec; 10(24):8235-42. PubMed ID: 15623599
[TBL] [Abstract][Full Text] [Related]
11. Immunolocalization of full-length NK1 tachykinin receptors in human tumors.
Schulz S; Stumm R; Röcken C; Mawrin C; Schulz S
J Histochem Cytochem; 2006 Sep; 54(9):1015-20. PubMed ID: 16651388
[TBL] [Abstract][Full Text] [Related]
12. Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms.
Kaemmerer D; Reimann C; Specht E; Wirtz RM; Sayeg M; Baum RP; Schulz S; Lupp A
Oncotarget; 2015 Feb; 6(5):3346-58. PubMed ID: 25671300
[TBL] [Abstract][Full Text] [Related]
13. VPAC2 receptor expression in human normal and neoplastic tissues: evaluation of the novel MAB SP235.
Schulz S; Mann A; Novakhov B; Piggins HD; Lupp A
Endocr Connect; 2015 Mar; 4(1):18-26. PubMed ID: 25504760
[TBL] [Abstract][Full Text] [Related]
14. CXCR4-based imaging agents.
Woodard LE; Nimmagadda S
J Nucl Med; 2011 Nov; 52(11):1665-9. PubMed ID: 22045705
[TBL] [Abstract][Full Text] [Related]
15. A mouse model for evaluation of efficacy and concomitant toxicity of anti-human CXCR4 therapeutics.
Costa MJ; Kudaravalli J; Liu WH; Stock J; Kong S; Liu SH
PLoS One; 2018; 13(3):e0194688. PubMed ID: 29554149
[TBL] [Abstract][Full Text] [Related]
16. Characterization and applications of a newly developed rabbit monoclonal antibody to cytokeratin 7 (CK7) for immunohistochemistry.
Qi W; Chu J; Zhou D; Tacha D
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):233-8. PubMed ID: 19098679
[TBL] [Abstract][Full Text] [Related]
17. Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CT.
Nimmagadda S; Pullambhatla M; Pomper MG
J Nucl Med; 2009 Jul; 50(7):1124-30. PubMed ID: 19525448
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of CCK1 cholecystokinin receptors in normal and neoplastic human tissues.
Schulz S; Röcken C; Mawrin C; Schulz S
J Clin Endocrinol Metab; 2005 Nov; 90(11):6149-55. PubMed ID: 16105969
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of a new monoclonal antibody against CXCR4 using lentivirus vector.
Li X; Kuang Y; Huang X; Zou L; Huang L; Yang T; Li W; Yang Y
Int Immunopharmacol; 2016 Jul; 36():100-105. PubMed ID: 27124560
[TBL] [Abstract][Full Text] [Related]
20. The intricate role of CXCR4 in cancer.
Chatterjee S; Behnam Azad B; Nimmagadda S
Adv Cancer Res; 2014; 124():31-82. PubMed ID: 25287686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
